Analysts from CGS-CIMB Research, DBS Group Research and PhillipCapital are mixed on Q&M Dental Group, and have maintained their “add”, “hold” and “buy” recommendations following the group’s results for the 3QFY2022 ended Sept 30.CGS-CIMB’s target price (TP) stood at 45 cents, up ...

Dental clinic operator Q&M announced that its 3QFY2022 earnings have declined by 62% y-o-y to $3.6 million from $9.5 million a year ago. This brings earnings per share to 0.38 cent per share, compared to 1.01 cent per share last year.This comes on the back of total revenue decreasing by 26% to $...

The two winners within this industry sector — Top Glove and Riverstone Holdings — are Malaysia-based, Singapore-listed glove makers who rode on a surge in demand for their products after the Covid-19 outbreak. Riverstone Holdings won returns to shareholders with a CAGR of 22%....

CGS-CIMB on Wednesday (Oct 12) raised its call on Q&M Dental Group to “add” from “hold”, as it views the current valuation of the group as “attractive”. 

CGS-CIMB Research has upgraded its recommendation on Q&M Dental Group to “add” from “hold” after the group’s diagnostics arm Acumen won a tender from the Ministry of Health (MOH) to operate a Joint Testing & Vaccination Center (JTVC).The tender is estimated to be worth $3.6 million...

THE following companies saw new developments that may affect trading of their securities on Wednesday (Oct 12): 

Acumen Diagnostics, a subsidiary of Q&M Dental group has won a tender from Singapore’s Ministry of Health to operate a Joint Testing and Vaccination Center (JTVC).Acumen is 51% owned by Q&M and 49% owned by Aoxin Q & M Dental, a spin off from Q&M itself.These centres provide testin...

1. What does Quantum Healthcare do? Quantum Healthcare is a healthcare company specialising in areas ranging from dental services, medical equipment and wellness services to R&D. Our recent internal restructuring and diversification into the healthcare business aims to bolster the long-term gro...

DBS Group Research analysts Yeo Kee Yan and Janice Chua believe that the 2QFY2022 performance of SGX-listed counters has “allayed” concerns of further lows.In a report dated Aug 24, the analysts write that the 2QFY2022 results season “debunked immediate slowdown concerns”, reflecting Singapo...

CGS-CIMB Research analysts Tay Wee Kuang and Kenneth Tan have downgraded Q&M Dental Group to “hold” from “add” due to the limited number of upside catalysts.The analysts have also slashed the group’s target price to 44 cents from 73 cents previously.“Following Q&M’s analyst bri...

CGS-CIMB on Friday (Aug 19) downgraded its call on Q&M Dental Group from “add” to “hold”, while lowering its target price on the stock to S$0.44 from S$0.73, on the back of an earnings miss and several near-term challenges. Q&M’s net profit of S$9.8 million for H1 e...

Healthcare is a “beneficiary” during periods of high inflation, says DBS Research analyst Rachel Tan in her healthcare industry report dated Aug 16.Given the global supply disruptions and ongoing geopolitical tensions, Singapore’s consumer price index (CPI) spiked from 2.29% in 2021 to 6.7% in...

Q&M Dental Group (Singapore) has reported lower earnings in tandem with a drop in testing services no longer as in high demand as before.For 2QFY2022 ended June, earning was down 60% y-o-y to $3.4 million, on the back of 13% drop in revenue to $44.1 million.For 1HFY2022 ended June, earnings was ...